Aclaris Therapeutics Inc. (ACRS)
NASDAQ: ACRS
· Real-Time Price · USD
1.88
0.19 (11.24%)
At close: Aug 15, 2025, 3:59 PM
1.83
-2.40%
After-hours: Aug 15, 2025, 07:57 PM EDT
Aclaris Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 25.4M | 30.36M | 24.57M | 47.65M | 22.83M | 35.84M | 39.88M | 39.04M | 31.15M | 44.72M | 45.28M | 61.65M | 68.26M | 36.34M | 27.35M | 53.6M | 113.45M | 35.27M |
Short-Term Investments | 74.4M | 74.96M | 89.02M | 80.07M | 88.26M | 92.33M | 79.23M | 64.01M | 88.63M | 126.08M | 172.29M | 186.41M | 180.34M | 143.28M | 164.06M | 144.28M | 118.23M | 93.03M |
Long-Term Investments | 81.08M | 85.21M | 90.3M | 45.71M | 38.78M | 33.2M | 62.77M | 83.94M | 90.99M | 33.6M | 12.24M | n/a | 7.22M | 23.95M | 34.24M | 45.73M | 34.5M | 14.36M |
Other Long-Term Assets | 2.99M | 3.15M | 3.07M | 3.22M | 262K | 281K | 1.74M | 2.66M | 2.89M | 3.27M | -630K | 2.92M | 3.11M | 3.38M | 3.55M | 3.74M | 3.91M | 4.01M |
Receivables | 194K | 250K | 318K | 343K | 325K | 373K | 298K | 346K | 431K | 686K | 484K | 597K | 637K | 633K | 623K | 811K | 939K | 817K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -83.94M | -90.99M | -33.6M | -12.24M | n/a | n/a | n/a | -34.24M | n/a | n/a | n/a |
Other Current Assets | 4.2M | 3.23M | 12.04M | 4.26M | 6.22M | 6.8M | 9.45M | 103.61M | 12.73M | 12.87M | 13.49M | n/a | n/a | 10.63M | 12.99M | 7.09M | 8.65M | 5.39M |
Total Current Assets | 104.2M | 108.79M | 125.95M | 132.33M | 117.64M | 135.34M | 128.86M | 123.07M | 132.94M | 184.36M | 231.55M | 256.57M | 259.35M | 190.88M | 205.03M | 205.78M | 241.26M | 134.5M |
Property-Plant & Equipment | 868K | 942K | 1.01M | 1.13M | 4.4M | 5.25M | 1.62M | 1.76M | 1.9M | 1.51M | 1.1M | 1.15M | 1.28M | 1.28M | 1.33M | 1.17M | 1.29M | 1.42M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | 269K | 6.92M | 6.93M | 6.95M | 6.97M | 6.99M | 7.01M | 7.03M | 7.05M | 7.07M | 7.09M | 7.11M |
Total Long-Term Assets | 84.94M | 89.3M | 94.38M | 50.06M | 43.44M | 38.73M | 68.55M | 95.29M | 102.71M | 45.34M | 23.05M | 11.06M | 18.62M | 35.65M | 46.18M | 57.71M | 46.78M | 26.9M |
Total Assets | 189.15M | 198.09M | 220.33M | 182.39M | 161.07M | 174.06M | 197.41M | 218.35M | 235.65M | 229.71M | 254.6M | 267.63M | 277.98M | 226.53M | 251.21M | 263.49M | 288.05M | 161.4M |
Account Payables | 8.8M | 6.35M | 4.69M | 7.66M | 7.27M | 10.81M | 8.88M | 9.65M | 11.43M | 8.19M | 10.35M | 7.67M | 5.7M | 8.12M | 9.98M | 7.56M | 4.24M | 7.29M |
Deferred Revenue | 9.33M | 3.89M | 3.89M | 3.77M | n/a | n/a | 19.45M | 15.16M | 8.74M | n/a | n/a | n/a | n/a | n/a | 10.05M | 7.41M | 6.93M | 3.6M |
Short-Term Debt | 515K | n/a | n/a | 465K | 449K | 503K | 426K | 310K | 458K | 603K | 684K | 766K | 741K | 716K | 693K | 669K | 647K | 625K |
Other Current Liabilities | 5.46M | 7.03M | 22.54M | 6.46M | 4.11M | 5.08M | -2.13M | -3.08M | 5.65M | 6.23M | 6.81M | 6.76M | 6.15M | 4.99M | 4.52M | 4.6M | 5.52M | 3.72M |
Total Current Liabilities | 26.84M | 21.51M | 31.6M | 18.82M | 15.68M | 20.08M | 30.95M | 27.32M | 22.83M | 18.26M | 21.94M | 19.79M | 16.22M | 16.73M | 22.93M | 17.84M | 14.92M | 14.51M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.73M | 10.69M |
Other Long-Term Liabilities | 10.5M | 11.32M | 11.02M | 10M | 9.2M | 9M | 6.2M | 32.5M | 32.7M | 34.27M | 34.67M | 27.64M | 25.64M | 29.23M | 30.57M | 28.71M | 28.22M | 23.54M |
Total Long-Term Liabilities | 30.57M | 32.51M | 33.18M | 33.43M | 11.57M | 11.97M | 9.27M | 34.7M | 33.07M | 34.64M | 35.04M | 28M | 26.01M | 29.6M | 30.94M | 29.07M | 39.31M | 34.6M |
Total Liabilities | 57.41M | 54.03M | 64.77M | 52.24M | 27.25M | 32.05M | 40.23M | 62.02M | 55.9M | 52.9M | 56.98M | 47.79M | 42.22M | 46.33M | 53.87M | 46.91M | 54.23M | 49.1M |
Total Debt | 2.37M | 2.48M | 2.6M | 2.71M | 2.82M | 3.47M | 3.5M | 2.14M | 458K | 603K | 684K | 766K | 741K | 716K | 693K | 669K | 11.38M | 11.32M |
Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | n/a |
Retained Earnings | -933.38M | -917.95M | -902.86M | -806.31M | -798.72M | -787.74M | -770.8M | -769.3M | -740.04M | -710.48M | -682.32M | -654.68M | -634.73M | -614.2M | -595.41M | -572.6M | -551.46M | -533.3M |
Comprehensive Income | 482K | 434K | 97K | 427K | -463K | -364K | -106K | -1.13M | -1.11M | -354K | -897K | -1.47M | -1.33M | -972K | -224K | -3K | -184K | -140K |
Shareholders Equity | 131.74M | 144.07M | 155.55M | 130.15M | 133.82M | 142.01M | 157.18M | 156.33M | 179.75M | 176.81M | 197.62M | 219.84M | 235.75M | 180.2M | 197.34M | 216.58M | 233.81M | 112.29M |
Total Investments | 155.49M | 160.17M | 179.33M | 125.78M | 127.04M | 125.52M | 142M | 147.96M | 88.63M | 159.68M | 184.54M | 186.41M | 187.56M | 167.24M | 198.31M | 190.01M | 152.73M | 107.39M |